Thursday, March 22, 2007 12:33:26 PM
Source: www.fdanews.com
March 22, 2007
Demand for nanotechnology medical products will grow by more than 17 percent annually to reach $53 billion in 2011, according to a recent report from The Freedonia Group. By 2016, new products such as nanodiagnostics, nanotech-based medical supplies and nanomedicines will drive demand to more than $110 billion, the report added.
Advances in nanotechnology will enhance the quality and performance of diagnostic products, the group said. For example, nanosized monoclonal antibody labels and DNA probes will improve the speed, accuracy, capabilities and cost effectiveness of in vitro diagnostic testing.
Nanoparticle formulations of superparamagnetic iron oxide, gadolinium, perfluorocarbon and specialty polymers used for in vivo imaging would allow the detection of tumors, plaque, genetic defects and other diseases at earlier stages and with lower, safer concentrations of injected compounds, the report said.
Freedonia anticipated these performance advantages and the broadening range of nanodiagnostics will increase demand for these products by 8.8 percent per year to reach $8.4 billion in 2011 and $12 billion in 2016.
Nanotechnology will also have greater applicability in medical supplies and devices, the group said, noting that nanomaterials are already used as active ingredients in burn dressings, bone cement, bone substitutes and dental repair and restoration products.
The group predicted that the long-term impact of nanotechnology will include new medical supply and device coatings, as well as new medical implants. In 2011, the market for nanomaterial-based medical supplies and devices is expected to hit $5.2 billion, compared with $400 million in 2006. This figure will reach $16.2 billion in 2016, the group predicted, as nanotech-based orthopedic and cardiac implants and nanocoated medical and surgical instruments are introduced.
In 2006, the five largest nanotech suppliers to the U.S. were Genentech, Johnson & Johnson, Abbott Laboratories, Amgen and Roche, with nearly 60 percent of the $23.6 billion U.S. market.
Recent SOTK News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/23/2024 06:05:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 11:21:13 AM
- Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog • GlobeNewswire Inc. • 05/23/2024 11:00:00 AM
- Sono-Tek Announces Year-End FY 2024 Earnings Conference Call • GlobeNewswire Inc. • 05/20/2024 11:00:00 AM
- Sono-Tek Announces Preliminary Net Sales for Q4 and FY2024 and Provides Preliminary Sales Guidance for Q1 FY2025 and FY2025 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- Sono-Tek Welcomes Dr. Adeniyi Lawal to Board of Directors • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Sono-Tek to Present at The LD Micro Invitational XIV • GlobeNewswire Inc. • 03/27/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 08:09:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:09:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 04:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:25:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:18:20 PM
- Sono-Tek Announces Appointment of Randy A. Copeman to Chief Technologist • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:39:22 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/31/2024 03:49:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:28:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:21:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:36:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:29:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:58:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/18/2024 04:01:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 02:07:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 01:10:47 PM
- Sono-Tek Reports 59% Increase in Q3 Fiscal 2024 Net Sales to Record $5.7 Million and Provides Sales Guidance for Fiscal Year 2024 • GlobeNewswire Inc. • 01/16/2024 01:00:51 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM